Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 2008;103:1309-1318
Published online before print October 16, 2008, doi: 10.1161/CIRCRESAHA.108.180042
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow Correction (v104,pe27)
Right arrow All Versions of this Article:
103/11/1309    most recent
CIRCRESAHA.108.180042v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Matsui, Y.
Right arrow Articles by Sadoshima, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Matsui, Y.
Right arrow Articles by Sadoshima, J.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*Protein
*UniGene
*Substance via MeSH
Related Collections
Right arrow Apoptosis
Right arrow Cell signalling/signal transduction
Right arrow Genetically altered mice
Right arrow Heart failure - basic studies
Right arrow Hypertrophy
(Circulation Research. 2008;103:1309.)
© 2008 American Heart Association, Inc.


Integrative Physiology

Lats2 Is a Negative Regulator of Myocyte Size in the Heart

Yutaka Matsui*, Noritsugu Nakano*, Dan Shao, Shumin Gao, Wenting Luo, Chull Hong, Peiyong Zhai, Eric Holle, Xianzhong Yu, Norikazu Yabuta, Wufan Tao, Thomas Wagner, Hiroshi Nojima, Junichi Sadoshima

From the Cardiovascular Research Institute (Y.M., N.N., D.S., S.G., W.L., C.H., P.Z., J.S.), Department of Cell Biology and Molecular Medicine and Department of Medicine, University of Medicine and Dentistry of New Jersey, New Jersey Medical School, Newark; Oncology Research Institute (E.H., X.Y., T.W.), Greenville, SC; Department of Molecular Genetics (N.Y., H.N.), Research Institute for Microbial Diseases, Osaka University, Japan; and Institute of Developmental Biology and Molecular Medicine (W.T.), Fudan University, Shanghai, People’s Republic of China.

Correspondence to Junichi Sadoshima, Cardiovascular Research Institute, New Jersey Medical School, Medical Science Building G-609, University of Medicine and Dentistry of New Jersey, 185 S Orange Ave, Newark, NJ 07103. E-mail Sadoshju{at}umdnj.edu

Mammalian sterile 20–like kinase (Mst)1 plays an important role in mediating apoptosis and inhibiting hypertrophy in the heart. Because Hippo, a Drosophila homolog of Mst1, forms a signaling complex with Warts, a serine/threonine kinase, which in turn stimulates cell death and inhibits cell proliferation, mammalian homologs of Warts, termed Lats1 and Lats2, may mediate the function of Mst1. We here show that Lats2, but not Lats1, dose-dependently increased apoptosis in cultured cardiac myocytes. Lats2 also dose-dependently reduced [3H]phenylalanine incorporation and cardiac myocyte size, whereas dominant negative Lats2 (DN-Lats2) increased them, suggesting that endogenous Lats2 negatively regulates myocyte growth. DN-Lats2 significantly attenuated induction of apoptosis and inhibition of hypertrophy by Mst1, indicating that Lats2 mediates the function of Mst1 in cardiac myocytes. Cardiac specific overexpression of Lats2 in transgenic mice significantly reduced the size of left and right ventricles, whereas that of DN-Lats2 caused hypertrophy in both ventricles. Overexpression of Lats2 reduced left ventricular systolic and diastolic function without affecting baseline levels of myocardial apoptosis. Expression of endogenous Lats2 was significantly upregulated in response to transverse aortic constriction. Overexpression of DN-Lats2 significantly enhanced cardiac hypertrophy and inhibited cardiac myocyte apoptosis induced by transverse aortic constriction. These results suggest that Lats2 is necessary and sufficient for negatively regulating ventricular mass in the heart. Although Lats2 is required for cardiac myocyte apoptosis in response to pressure overload, it was not sufficient to induce apoptosis at baseline. In conclusion, Lats2 affects both growth and death of cardiac myocytes, but it primarily regulates the size of the heart and acts as an endogenous negative regulator of cardiac hypertrophy.


Key Words: apoptosis • cardiac hypertrophy • heart failure • signal transduction




This article has been cited by other articles:


Home page
Sci SignalHome page
G. Blandino, Y. Shaul, S. Strano, M. Sudol, and M. Yaffe
The Hippo Tumor Suppressor Pathway: A Brainstorming Workshop
Sci. Signal., November 3, 2009; 2(95): mr6 - mr6.
[Abstract] [Full Text] [PDF]